Showing 11-20 of 34 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Tirzepatide with fully automated insulin delivery | The Research Institute of the McGill University Health Centre | Ahmad Haidar | Improving Lives | 01-September-2025 to 31-August-2028 | $1,885,343.91 |
| Combinatory Technologies to Optimized Localized Drug Delivery for Cell Therapies in T1D | The University of Alberta | Gregory Korbutt | Cures | 01-July-2024 to 30-June-2027 | $896,925.01 |
| Graft localized therapeutic delivery systems to enhance beta cell engraftment | The University of Alberta | Gregory Korbutt | Cures | 01-October-2023 to 30-September-2026 | $974,655.00 |
| AI-driven benchmarking for understanding and improving SC-islets | The University of Alberta | Patrick MacDonald | Cures | 01-May-2025 to 30-April-2028 | $750,000.00 |
| Identification of islet macrophage-derived factors mediating human beta cell regeneration | The University of British Columbia | C. Bruce Verchere | Cures | 01-July-2021 to 31-March-2025 | $299,860.00 |
| Subcellular proteomic profiling of human primary and stem cell derived beta cells: A blueprint for making better beta cells | The University of British Columbia | Haoning Cen | Cures | 01-March-2025 to 29-February-2028 | $264,895.00 |
| Image-based phenotyping of stem cell derived islets | The University of British Columbia | Hongshen Ma | Cures | 01-September-2025 to 31-August-2028 | $750,000.00 |
| BimT1D | The University of British Columbia | Jan Dutz | Cures | 01-September-2025 to 31-August-2029 | $2,488,315.00 |
| Clinical Phase II/III Trial to treat type 1 diabetes (UST1D2) | The University of British Columbia | Jan Dutz | Cures | 01-November-2020 to 31-December-2027 | $538,854.00 |
| Modulation of immune cell fate and function by the islet secretome in health and diabetes | The University of British Columbia | Lauar de Brito Monteiro | Cures | 01-March-2024 to 28-February-2027 | $243,055.00 |